Status:
COMPLETED
Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation
Lead Sponsor:
National Institute of Cardiology, Laranjeiras, Brazil
Conditions:
Arterial Hypertension
Resistant Arterial Hypertension
Eligibility:
All Genders
18-80 years
Brief Summary
It has been proposed that the modulation of the activity of the sympathetic nervous system, through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vasc...
Detailed Description
Arterial hypertension is still a serious public health problem with considerable social and economic impact. Arterial hypertension is the result from a complex interaction between environmental and ge...
Eligibility Criteria
Inclusion
- Resistant arterial hypertension under pharmacological treatment
Exclusion
- secondary arterial hypertension
- renal dysfunction
- severe kidney disease
- congestive heart failure
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 6 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03243045
Start Date
March 1 2017
End Date
January 6 2020
Last Update
January 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cardiology
Rio de Janeiro, Brazil, 21040-360